Aiolos Bio

Aiolos Bio

Biotechnology Research

San Francisco, CA 3,750 followers

About us

At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immunological disorders. Our goal is to provide patients and caregivers with more efficacious therapies that significantly reduce treatment burden. Our vision is embodied in our current focus – the development of a groundbreaking anti-TSLP therapy with best-in-class potential. We are a San Francisco Bay area-based clinical stage biopharma company with additional operations in London, UK. The Aiolos team is comprised of seasoned drug developers, who have successfully developed and launched products for a range of immune conditions, including asthma, rheumatoid arthritis, IPF, and more. As we grow, we will look to add like-minded individuals to our team - those committed to the goal of providing a meaningful difference in the lives of patients suffering from respiratory illnesses and other immune disorders.

Website
AiolosBio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
San Francisco, CA
Type
Privately Held
Founded
2023

Locations

Employees at Aiolos Bio

Updates

Affiliated pages

Similar pages

Funding